Pemetrexed as maintenance therapy for advanced, non-squamous, non-small cell lung cancer (NSCLC)

About 2,600 new cases of lung cancer are diagnosed each year in Norway, of which 80% are classified as non-small cell lung cancer (NSCLC). Of these, about 75% have locally advanced or metastatic disease at the time of diagnosis. Palliative chemotherapy is the standard treatment for patients in NSCLC...

Full description

Bibliographic Details
Main Author: Movik, Espen
Corporate Author: Nasjonalt kunnskapssenter for helsetjenesten
Format: eBook
Published: Oslo Norwegian Knowledge Centre for the Health Services June 2012, 2012
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Table of Contents:
  • Includes bibliographical references